期刊文献+

生化制药的研究进展 被引量:2

Progress of the Research on Bio-chem ical Drug Making
下载PDF
导出
摘要 目的:综述生化制药的研究进展。方法:根据目前的信息对生化制药的研究现状进行重点阐述。结果:传统的生化制药回收率低,现代生化制药发展较快,预计未来的生化制药将有长足的发展。结论:生化制药前景广阔。 Objective:To summarize the developments in the research on bio -chemical drug makin g.Methods:Description of the current situation of bio -chem ical drug making based on available i nformation.Results:Conventional bio -chemical drug making technologies yield low r esults.Thanks to the rapid progress of modern bio -chemical technology,multiple bio -technologies have been applied to dr ug making.Conclusion:The prospect for bio -chemical drugs is promising.
出处 《中国药业》 CAS 2003年第8期23-25,共3页 China Pharmaceuticals
关键词 生化制药 生物技术 新药 基因科学 Bio -chemical drug making biologic al technology new drug genetic science
  • 相关文献

参考文献12

二级参考文献67

共引文献66

同被引文献13

  • 1马志英.新理论新方法影响下的制药新技术发展[J].卫生职业教育,2005,23(3):92-94. 被引量:1
  • 2Drews J. Drug discovery:a historical perspective[J]. Science,2000,287(5460) :1960-1964.
  • 3Terstappen GC,Reggiani A. In silico research in drug discovery[J]. Trends Pharmacol Sci, 2001,22 (1): 23-26.
  • 4Robert FS. High-speed biologists search for gold in proteins [J ]. Science, 2001,294(5549): 2074-2082.
  • 5Eliot M. A physicist-turned-biologist [J]. Science, 2001, 294(5549):2085.
  • 6Liggett SB. Pharmacogenetic applications of the human genome project[J]. Nat Med, 2001,7 (3): 281-283.
  • 7Dancey JE,Freidlin B. Targeting epidermal growth factor receptor- are we missing the mark [J]? Lancet, 2003, 362(9377): 62-64.
  • 8Asai A, Oshima Y, Yamamoto Y, et al. A novel telomerase template antagonist (GRN163) as a potential anticancer agent [J]. Cancer Res,2003,63(14): 3931-3939.
  • 9Stacher G. Cilansetron. Solvay[J]. Curr Opin Investig Drugs,2001,2(10): 1432-1436.
  • 10Rivkin A. Tegaserod maleate in the treatment of irritable bowel syndrome: a clinical review [J]. Clin Ther, 2003, 25 (7):1952-1974.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部